Breaking News

ICON Adds COO Role, Names Team Leaders

By Kristin Brooks | January 10, 2014

Cutler to oversee all ops, Murphy and Miskel take on Clinical and Lab units

Dr. Steve Cutler has been appointed to the newly created position of chief operating officer at ICON plc. Dr. Cutler will be responsible for the company’s operational units, covering Early Phase, Clinical, Laboratories, Commercialization and Outcomes and DOCS FSP & resourcing. Dr. Cutler will also be responsible for ICON’s sales and marketing and strategic alliance teams. He joined the company in November 2011 as group president, Clinical Research Services. 
 
Within Dr. Cutler’s team, Dr. Nuala Murphy has been appointed president, ICON Clinical Services, and Jim Miskel has been appointed executive vice president and general manager, ICON Laboratory Services. 
 
Dr. Murphy will oversee ICON’s global clinical services, including clinical and data operations, study start-up, project management, clinical risk management, technology services and clinical scientific operations. Dr. Murphy joined ICON in 2012 as executive vice president, Global Clinical Operations and Data Management.
 
Mr. Miskel will lead ICON’s newly combined Central and Bioanalytical laboratories group. He joined the company in November 2013 and brings extensive lab and pharma industry experience.
 
Ciaran Murray, chief executive officer of ICON, said, “We continually review our structure to ensure that as the market evolves, our organization can continue to provide customers with innovative and integrated solutions across our various service lines and business units. Bringing all operational units under Steve’s leadership will allow us to further enhance the support we can offer to our customers’ development programs. I would like to congratulate Steve, Nuala and Jim on their new roles and wish them every success in the future.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.